30 June 2022
Drug reviews and drug licensing
Showing results 11 - 20 of 100
Sorted by most recent
29 June 2022
26 April 2022
23 February 2022
11 January 2022
19 August 2021
19 July 2021
26 November 2020
28 September 2020
4 March 2020
Validation period: 10/4/2023, 10:42:12 AM - 10/11/2023, 10:42:12 AM
Safety update: monitoring patients taking amiodarone ▼Inclisiran: more hope less hype Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir Naldemedine for opioid-induced constipation Dapagliflozin no longer licensed for type 1 diabetes ▼Romosozumab for osteoporosis Chloramphenicol eye drops: ok to use in children younger than 2 years Esketamine for treatment-resistant depression Three new drugs for the prevention of migraine EMA suspends licence for ingenol mebutate (Picato)